53
3
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TP1040 |
Calcitonin (salmon)
鲑降钙素,Calcitonin salmon,Salmon calcitonin |
CGRP Receptor | GPCR/G Protein; Neuroscience |
Calcitonin (salmon) 是一种阿米林和卡西宁受体的双激动剂,是一种钙调节激素,能够刺激骨的生成并能抑制骨吸收。 | |||
TP1040L |
Calcitonin(salmon) Acetate(47931-85-1(free base))
Salmon calcitonin |
CGRP Receptor | GPCR/G Protein; Neuroscience |
Calcitonin(salmon)Acetate (47931-85-1(free base))(Salmon calcitonin) 是一种钙调节激素,用于治疗绝经后至少 5 年的女性骨质疏松症。 | |||
TP1028L |
Calcitonin eel acetate
Calcitonin eel acetate (57014-02-5 Free base),降钙素,Thyrocalcitonin eel |
Others | Others |
Calcitonin eel acetate (Calcitonin eel acetate (57014-02-5 Free base)) 是调节钙稳态的甲状腺激素肽。 | |||
TP1200 |
CGRP (83-119), rat TFA
Calcitonin Gene Related Peptide(83-119), rat TFA |
Others | Others |
CGRP (83-119), rat TFA (Calcitonin Gene Related Peptide(83-119), rat TFA) 是一种由 37 个氨基酸组成的神经肽降钙素家族,通过降钙素受体样受体起作用。 | |||
T37413 |
Calcitonin (salmon) (trifluoroacetate salt)
|
||
Calcitonin is a peptide hormone that lowers blood calcium level and inhibits bone resorption. It belongs to the calcitonin family of peptides, which also includes amylin , calcitonin gene-related peptide , and adrenomedullin. The binding of salmon calcitonin to the human calcitonin receptor (CTR) is not modulated by receptor activity-modifying proteins (RAMPs), which influence affinity of human calcitonin to CTR. Salmon calcitonin binds to human CTR2 with IC50 values of 0.933, 0.224, 0.134, and ... | |||
TP2055 |
Calcitonin (human)
|
||
Endogenous calcitonin receptor agonist. Lowers systemic blood calcium levels and inhibits bone resorption. | |||
TP1027 |
Calcitonin, eel TFA (57014-02-5 free base)
Thyrocalcitonin eel (TFA),Calcitonin, eel TFA |
||
Calcitonin,eel TFA is a thyroid hormone polypeptide that can regulate calcium homeostasis and is widely used in the study of postmenopausal osteoporosis. | |||
TP1028 |
Calcitonin, eel
Thyrocalcitonin eel |
||
Calcitonin, eel is a peptide hormone that plays a crucial role in maintaining calcium balance within the body. It is extensively utilized in the scientific investigation of postmenopausal osteoporosis, a condition characterized by decreased bone density and an increased risk of fractures in women after menopause. | |||
T78372 |
Calcitonin, eel TFA
Thyrocalcitonin eel TFA |
||
Calcitonin, eel TFA,一种甲状腺激素多肽,调节钙稳态,主要应用于绝经后骨质疏松症研究。 | |||
TP1677 |
Calcitonin (8-32), salmon
|
||
Calcitonin (8-32), salmon is a highly selective amylin receptor antagonist.Calcitonin is a hormone known to participate in calcium and phosphorus metabolism. In mammals, the major source of calcitonin is from the parafollicular or C cells in the thyroid g | |||
TP1202 |
Calcitonin Gene Related Peptide (CGRP) II, rat
CGRP II, rat |
||
Calcitonin Gene Related Peptide II is a potent, long-lasting vasodilator; activation of CGRP receptors on pancreatic β-cells increases plasma levels of pancreatic enzymes. | |||
TP1203 |
CGRP(83-119), rat
Calcitonin Gene Related Peptide (CGRP) (83-119), rat |
||
Calcitonin Gene Related Peptide (CGRP) (83-119), rat is a 37 amino acid calcitonin family of neuropeptide, acts through calcitonin receptor-like receptor. | |||
TP1201 |
CGRP II, rat (TFA) (99889-63-1 free base)
Calcitonin Gene Related Peptide (CGRP) II, rat (TFA),CGRP II, rat (TFA) |
||
Calcitonin Gene Related Peptide (CGRP) II, rat (TFA) is a neuropeptide with 37 amino acid. | |||
T17194 |
Ubrogepant
MK-1602 |
CGRP Receptor | GPCR/G Protein; Neuroscience |
Ubrogepant (MK-1602) 是新型的、口服有效的降钙素基因相关肽受体拮抗剂。Ubrogepant 有潜力用于急性偏头痛的相关研究。 | |||
T76363 |
[Tyr22] Calcitonin Gene Related Peptide, (22-37), rat
|
||
[Tyr22]CalcitoninGene Related Peptide, (22-37), rat 是一种大鼠降钙素基因相关肽 (CGRP) 的 22-37 片段,靶向CGRP 受体和腺苷酸环化酶。降钙素 (calcitonin) 主要由甲状腺 C 细胞产生,而 CGRP 则分泌并储存在神经系统中。 | |||
T76032 |
Calcitonin Gene Related Peptide (CGRP) II, rat TFA
|
||
CalcitoninGene Related Peptide (CGRP) II, rat TFA,为CGRP受体激活剂,具有显著且持久的血管扩张效果,适用于心血管疾病研究。 | |||
T12293L |
Olcegepant
BIBN-4096,BIBN 4096BS |
CGRP Receptor | GPCR/G Protein; Neuroscience |
Olcegepant (BIBN-4096) 是一种选择性的降钙素基因相关肽1 (CGRP1) 受体拮抗剂,IC50=0.03 nM,Ki=14.4 pM。 | |||
T8682 |
Vazegepant hydrochloride
Vazegepant HCl |
CGRP Receptor | GPCR/G Protein; Neuroscience |
Vazegepant hydrochloride (Vazegepant HCl) 是一种用于偏头痛的鼻用 gepant,是一种高度亲和性CGRP 受体拮抗剂 (hCGRPKi=0.023 nM)。它可能有助于有效管理 COVID-19 相关肺部炎症。 | |||
T4610 |
Rimegepant
BMS 927711,BMS-927711,BMS927711,BHV-3000 |
CGRP Receptor | GPCR/G Protein; Neuroscience |
Rimegepant (BMS 927711) 是一种有效的降钙素基因相关肽 (CGRP) 受体拮抗剂,其 Ki=0.027 nM,IC50=0.14 nM。 | |||
T6590 |
MK-3207 Hydrochloride
MK-3207 HCl |
CGRP Receptor | GPCR/G Protein; Neuroscience |
MK-3207 Hydrochloride (MK-3207 HCl) 是口服具有活力的CGRP receptor 拮抗剂,IC50=0.12 nM,Ki=0.024 nM。 | |||
TP2233L |
CGRP (rat) acetate
|
Others | Others |
CGRP (rat) acetate 是一种降钙素基因相关肽(CGRP)。它是一种有效的血管扩张剂。 | |||
TP1257L |
Adrenomedullin (AM) (22-52), human acetate
Adrenomedullin (AM) (22-52), human acetate(159899-65-7 Free base) |
CGRP Receptor | GPCR/G Protein; Neuroscience |
Adrenomedullin (AM) (22-52), human acetate 是猫后肢血管床中 CGRP 受体和肾上腺髓质素受体的拮抗剂。 | |||
T76874 |
Erenumab
AMG-334 |
CGRP Receptor | GPCR/G Protein; Neuroscience |
Erenumab是一种全人单克隆抗体,作用于抑制降钙素基因相关肽(CGRP)受体,用于预防发作性偏头痛。 | |||
TP1134L |
HCGRP-(8-37) acetate
HCGRP-(8-37) acetate (119911-68-1 free base) |
CGRP Receptor | GPCR/G Protein; Neuroscience |
HCGRP-(8-37) acetate 是一种人降钙素基因相关肽 (hCGRP) 片段醋酸盐,也是 CGRP 受体的拮抗剂。 | |||
T76682 |
Galcanezumab
LY 2951742 |
CGRP Receptor | GPCR/G Protein; Neuroscience |
Galcanezumab 是一种靶向 CGRP 配体的人源化 IgG4 单克隆抗体,是一种与配体降钙素基因相关肽结合的抗体。Galcanezumab 可用于预防和治疗偏头痛或丛集性头痛。 | |||
T23406 |
SUN B8155
SUN-B 8155 |
Others | Others |
calcitonin (CT) receptor agonist | |||
T26682 |
Atogepant
MK 8031,MK8031. Atogepant,MK-8031 |
||
Atogepant is an antagonist of calcitonin gene-related peptide receptor. | |||
TP2049 |
CRSP-1
|
||
Endogenous central calcitonin (CT) receptor agonist that stimulates cAMP formation at a potency 350-fold greater than CT (ED50 values are 0.2 and 71 nM respectively). Displays no activity at calcitonin-gene related peptide (CGRP) and adrenomedullin recept | |||
T39522 |
HTL22562
|
||
HTL22562 is a calcitonin gene-related peptide (CGRP) receptor antagonist for acute treatment of migraine. | |||
T12293 |
Olcegepant hydrochloride
BIBN-4096 hydrochloride,BIBN4096BS hydrochloride |
Others | Others |
Olcegepant hydrochloride is a potent and selective non-peptidethe calcitonin gene-related peptide 1 (CGRP1) receptor antagonist (with IC50 of 0.03 nM for human CGRP). | |||
TP1131 |
β-CGRP, human TFA (101462-82-2 free base)
CGRP-II (Human) (TFA),Human β-CGRP (TFA),β-CGRP, human TFA |
||
β-CGRP,human tissue is one of the calcitonin peptide, through complex behavior of calcitonin receptor like receptor (CRLR) - and receptor activity - modifying proteins (increased), and 1 and 300 - nM CRLR IC50s/RAMP1 and CRLR/RAMP2 cells. | |||
T75978 |
β-CGRP, human TFA
|
||
β-CGRP, human TFA (Human β-CGRP TFA) 是一种降钙素肽,通过降钙素受体样受体CRLR 与RAMP 的复合物起作用,在细胞体系中,对 CRLR/RAMP1 和 CRLR/RAMP2 的IC50值分别为 1 nM 和 300 nM。 | |||
TP2044 |
α-CGRP(human)
α-CGRP (human) |
||
Endogenous calcitonin gene-related peptide receptor (CGRP) agonist. | |||
T26796 |
BI-44370
|
||
BI-44370, a CGRP (calcitonin gene-related peptide) receptor antagonist, can be used to treat migraines and other chronic pain. | |||
T70248 |
4991W93
|
||
4991W93 is a 5HT(1B/1D) receptor partial agonist, inhibiting electrically induced plasma extravasation, blocking neurogenic plasma protein extravasation, inhibiting release of calcitonin gene-related peptide. | |||
T16093 |
Telcagepant
MK-0974 |
Others | Others |
Telcagepant is an orally active antagonist of calcitonin gene-related peptide (CGRP) receptor (Kis: 0.77 nM and 1.2 nM for human and rhesus CGRP receptors, respectively). | |||
T71246 |
DD04107
|
||
DD04107 is a novel inhibitor of α-calcitonin gene-related peptide (α-CGRP) exocytotic release from primary sensory neurons, selectively interacting with Synaptotagmin 1. | |||
T27025 |
Cizolirtine citrate
E-4018,E4018,E 4018 |
||
Cizolirtine is a calcitonin gene-related peptide antagonist. Cizolirtine may be useful for alleviating some neuropathic somatosensory disorders, in particular cold allodynia, with a reduced risk of undesirable side effects. Cizolirtine inhibits the spinal | |||
TP1130 |
β-CGRP, human
CGRP-II (Human),Human β-CGRP |
||
β-CGRP, human ,a 37-amino acid peptide,is the beta form of Calcitonin-gene-related peptide (β-CGRP), involved extensively in regulation of the cardiovascular and nervous systems. β-CGRP contains a disulphide bridge at the N-terminus, a C-terminal phenylal | |||
T73703 | (3R,5R,6S)-Atogepant | ||
(3R,5R,6S)-Atogepant ((3R,5R,6S)-MK-8031) 是Atogepant 的异构体.Atogepant 是降钙素基因相关肽受体 (CGRP) 拮抗剂。Atogepant 可用于研究偏头痛。 | |||
T76678 | Eptinezumab | ||
Eptinezumab为人源化单克隆抗体,主要通过与降钙素基因相关肽(CGRP)结合,进而阻止其与受体相结合,用于成人偏头痛的预防。 | |||
TP1232 |
Amylin, amide, rat
Amylin (rat) |
||
Amylin is a peptide that displays 50% homology with calcitonin gene-related peptide (CGRP), Amylin is colocalized with somatostatin in endocrine cells of the gastric fundus. In isolated mouse stomach, amylin caused a concentration-dependent decrease in ac | |||
TP1625 |
Adrenomedullin (11-50), rat
|
||
Adrenomedullin 11-50 rat is a peptide fragment of adrenomedullin that possesses systemic vasodilator activity at the level of calcitonin gene-related peptide-1 (CGRP1) receptor activation. Adrenomedullin and its peptide may be used in bone growth studies. | |||
TP1954 |
PHM-27 (human)
|
||
Endogenous peptide product of human prepro-VIP and analog of porcine PHI-27; potent agonist for the human calcitonin receptor (EC50 = 11 nM). Transgenic mice expressing the human VIP/PHM 27 gene in pancreatic β-islets display enhanced glucose-induced insu | |||
TP1183 |
Amylin, amide, human
DAP amide, human |
||
Amylin, a 37-amino acid polypeptide that is structurally related to calcitonin, is secreted from the B cells of the pancreas. Amylin has anoretic effects in rats. Amylin may be responsible for the etiology of insulin resistance of type II diabetes mellitu | |||
T70837 | Rimegepant sulfate hydrate | ||
Rimegepant, also known as BMS-927711 and BHV-3000, is a potent, selective, competitive, and orally active calcitonin gene-related peptide (CGRP) antagonist in clinical trials for treating migraines. Rimegepant has shown in vivo efficacy without vasoconstriction effect. BMS-927711 is superior to placebo at several different doses (75 mg, 150 mg, and 300 mg) and has an excellent tolerability profile. | |||
T76262 |
Cagrilintide
|
||
Cagrilintide为一种处于研发阶段的新型长效酰化胰岛素类似物,兼具非选择性胰岛素受体(AMYR)与降钙素G蛋白偶联受体(CTR)的激动剂功能。该化合物能显著降低体重并减少食物摄入,展现出针对肥胖疾病的研究潜力。 | |||
T76680 | Fremanezumab | ||
Fremanezumab (TEV-48125) 是一种人源化IgG2a 单克隆抗体,可选择性且有效地与降钙素基因相关肽 (CGRP) 结合。CGRP 是一种 37 个氨基酸的神经肽,参与偏头痛的中枢和外周病理生理事件。Fremanezumab 具有用于慢性偏头痛研究的潜力。 | |||
T75934 |
AC 187 TFA
|
||
AC 187 TFA 是一种有效且具有口服活性的胰淀素受体 (amylin receptor) 拮抗剂,IC50为 0.48 nM,Ki 为 0.275 nM。AC 187 TFA 对胰淀素受体的选择性高于降钙素和 CGRP 受体。AC 187 TFA 具有神经保护作用。 | |||
T36555 |
Tyr-α-CGRP (human) (trifluoroacetate salt)
|
||
Tyr-α-CGRP is an N-terminal extended tyrosinated analogue of α-calcitonin gene-related peptide . It binds to amylin receptors AMY1 and AMY3 in COS-7 cells expressing the human receptors (IC50s = 141 and 1.86 nM, respectively). Tyr-α-CGRP also binds to and stimulates cAMP accumulation in rat L6 myocytes (IC50 = 4 nM; EC50 = 12 nM). It also binds to rat brain and spleen membrane preparations (IC50s = 0.2 and 0.5 nM, respectively), induces positive chronotropic and inotropic effects in isolated rig... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TP2167 |
β-CGRP, human acetate
β-CGRP, human acetate (101462-82-2 free),CGRP-II (Human) (acetate),Human β-CGRP acetate |
CGRP Receptor | GPCR/G Protein; Neuroscience |
β-CGRP, human acetate 是降钙素肽之一,通过受体活性修饰蛋白 (RAMP) 和降钙素受体样受体 (CRLR) 的复合物发挥作用(对于 CRLR/RAMP1 和 CRLR,IC50:1 nM 和 300 nM /RAMP2 在单元格中)。 | |||
T15157 |
Dodecanoylcarnitine
Lauroylcarnitine |
Endogenous Metabolite | Metabolism |
Dodecanoylcarnitine((-)-Lauroylcarnitine) 和脂肪酸氧化紊乱有关,使用 Dodecanoylcarnitine 可使鲑鱼降钙素的通透性增加。 | |||
T21581L |
AC 187 Acetate
AC 187 Acetate (151804-77-2 Free base) |
Amylin Receptor | GPCR/G Protein |
AC 187 Acetate 是胰淀素受体的强效拮抗剂。AC 187 对胰淀素受体的选择性高于降钙素和 CGRP 受体。 |